Most Read This Week
- Predictors of Response to CDK4/6i Retrial After Prior CDK4/6i Treatment Failure in ER+ Metastatic Breast Cancer
- Ponsegromab for Treating Cancer Cachexia
- PSA Screening Combined With MRI-Targeted Biopsy for Detecting Prostate Cancer
- Long-Term Outcomes After Perioperative Chemotherapy and Nivolumab for NSCLC
- Induction Chemotherapy Followed by Standard Chemoradiotherapy vs Standard Chemoradiotherapy Alone for Locally Advanced Cervical Cancer
Recently Updated
- Pathological Response Following Neoadjuvant Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma
- Uninsurance Plays Major Role in Racial Disparities Seen in Cancer Diagnosis
- ACG: GLP-1 RAs Tied to Lower Risk for Early-Onset Colorectal Cancer
- Inavolisib + Palbociclib-Fulvestrant Improves Survival in Advanced Breast Cancer
- ACG: 2000 to 2022 Saw Rise in Early-Onset CRC Mortality in the United States